personalized LADD-based immunotherapy (Aduro BioTech)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepersonalized LADD-based immunotherapy (Aduro BioTech)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsColorectal NeoplasmsGastrointestinal NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChinook Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChinook Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsColorectal NeoplasmsGastrointestinal NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A